In a 44-year-old woman with a negative cervical cytology (Pap test) alone, when should the next screening be performed: in three years or five years?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Screening Interval for 44-Year-Old Woman with Negative Pap Smear

A 44-year-old woman with a negative Pap test alone should return for screening in 3 years, not 5 years.

Rationale Based on Current Guidelines

The American Cancer Society guidelines are clear and consistent on this point: for women aged 30-65 years who undergo cytology (Pap test) alone, screening should be performed every 3 years 1, 2, 3. The 5-year interval is reserved specifically for co-testing (combined HPV and Pap testing), which is the preferred strategy for this age group 1, 2.

Understanding the Screening Strategy Options

For women in the 30-65 age range, there are two acceptable approaches:

  • Preferred approach: Co-testing with both HPV and Pap tests every 5 years 1, 2, 3
  • Acceptable alternative: Pap test (cytology) alone every 3 years 1, 2, 3

Since your patient received only a Pap test (cytology alone), she falls into the second category and must follow the 3-year interval.

Why Not 5 Years?

The evidence supporting screening intervals demonstrates that cytology alone does not provide the same level of reassurance as co-testing 3. Studies show an incremental rise in cancer risk when the interval from the last negative cytology test extends beyond 3 years 3. The addition of HPV testing to cytology results in increased detection of prevalent high-grade lesions and provides lower risk following a negative screen, which permits the longer 5-year interval 3.

The 5-year interval applies only when HPV testing is included with cytology - this combination provides enhanced identification of women at risk, including those with adenocarcinoma precursors that cytology alone may miss 3.

Clinical Pitfall to Avoid

A common error is assuming that all negative screening results in women aged 30-65 warrant a 5-year interval. This is incorrect. The screening interval depends on the test performed, not just the patient's age. Even with a history of multiple consecutive negative cytology results, the evidence does not support extending the interval beyond 3 years when using cytology alone 3.

Practical Recommendation

Schedule this patient's next Pap test in 3 years. If you wish to extend her screening interval to 5 years in the future, you must switch to co-testing (HPV + Pap) or primary HPV testing, both of which support the longer interval 1, 2, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.